retatrutide glp-1 gip glucagon ly3437943 triple agonist mechanism Beyond GLP -1: Retatrutide's triple-agonist (GLP-1, GIP, glucagon) is redefining metabolic health. Phase 2 data shows ~24% weight loss—surpassing semaglutide & tirzepatide. Evidence-based Retatrutide is considered the newest
Pay in 4 interest-free payments of $6.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1




00125-7/asset/c8ecd4ec-8b7c-48e1-bb82-1c56292e9cbf/main.assets/gr3_lrg.jpg)




















